市場調查報告書
商品編碼
1458142
全球牛市場規模、佔有率和成長分析:按最終用戶和應用分類 - 產業預測(2024-2031)Global Fetal Bovine Serum Market Size, Share, Growth Analysis, By End-user(Pharmaceutical & Biotechnology Companies, Contract & Academic Research Organizations), By Application(Drug Discovery, In-vitro Fertilization) - Industry Forecast 2024-2031 |
全球牛市場規模將從2023年的17.9億美元增加至2022年的15.7億美元,在預測期內(2024-2031年)複合年成長率為14.1%,預計將成長至51.5億美元到2031年。
全球牛(FBS)市場的主要目標是滿足生物醫學研究和開發中對優質細胞培養補充品不斷成長的需求。有幾個因素促進了這個市場的擴張。首先,生物技術和製藥領域研發活動投資的增加正在推動對胎牛血清的需求。其次,慢性病的盛行率不斷上升以及對有效治療解決方案的需求需要進行廣泛的細胞研究,從而推動了對胎牛血清的需求。然而,全球牛市場正面臨各種挑戰。關鍵挑戰之一是胎牛血清批次的品質和成分的可變性,這可能會影響研究結果的再現性和可靠性。儘管如此,這個市場仍然存在著成長和創新的機會。作為胎牛血清替代品的無血清培養基和化學成分確定的培養基配方的出現,為市場相關人員提供了滿足對不含動物成分的細胞培養解決方案的需求的途徑。全球牛市場在支持生物醫學研究和細胞培養應用方面發揮著至關重要的作用。儘管面臨道德問題、監管限制和品質差異,但市場提供了創新和探索替代解決方案的機會。對細胞研究、再生醫學和生技藥品的需求不斷成長正在推動市場發展,凸顯了高品質胎牛血清在科學突破和治療方法進展中的重要性。
Global Fetal Bovine Serum Market size was valued at USD 1.57 billion in 2022 and is poised to grow from USD 1.79 billion in 2023 to USD 5.15 billion by 2031, by rising at a CAGR of 14.1% during the forecast period (2024-2031).
The primary objective of the global fetal bovine serum (FBS) market is to address the rising need for premium-quality cell culture supplements in biomedical research and development. Several factors contribute to the expansion of this market. Firstly, the growing investments in research and development activities across the biotechnology and pharmaceutical sectors drive the demand for FBS. Secondly, the increasing prevalence of chronic diseases and the imperative for effective therapeutic solutions necessitate extensive cell-based research, thereby boosting the demand for FBS. However, the global fetal bovine serum market encounters various challenges. One significant challenge is the variability in the quality and composition of FBS batches, which can impact the reproducibility and reliability of research outcomes. Nonetheless, the market presents opportunities for growth and innovation. The emergence of serum-free and chemically defined media formulations as substitutes to FBS creates avenues for market players to cater to the demand for animal component-free cell culture solutions. The global fetal bovine serum market holds a pivotal role in supporting biomedical research and cell culture applications. Despite facing ethical concerns, regulatory restrictions, and quality variability, the market offers opportunities for innovation and the exploration of alternative solutions. The escalating demand for cell-based research, regenerative medicine, and biologics drives the market, underscoring the significance of high-quality FBS in advancing scientific breakthroughs and therapeutic advancements.
Top-down and bottom-up approaches were used to estimate and validate the size of the global fetal bovine serum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Fetal Bovine Serum Market Segmental Analysis
The global fetal bovine serum market is segmented based on end-user, application, and region. By end-user, the market is segmented into pharmaceutical & biotechnology companies, contract & academic research organizations. By application, the market is segmented into drug discovery, in-vitro fertilization, vaccine production, cell-based research, diagnostics, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Fetal Bovine Serum Market
The biopharmaceutical industry experienced substantial growth, prioritizing the development of innovative therapeutic solutions. Fetal bovine serum (FBS), playing a crucial role in cell culture-based research, saw widespread use in drug discovery, preclinical testing, and biologics production. The heightened investment in biopharmaceutical research and development activities propelled the demand for FBS.
Restraints in the Global Fetal Bovine Serum Market
The utilization of animal-derived products, such as FBS, raised ethical concerns among certain researchers and regulatory bodies. The imperative to minimize or eradicate animal-derived components in cell culture systems prompted the investigation of alternative serum-free and defined media formulations. The presence of these alternatives presented a challenge to the expansion of the FBS market.
Market Trends of the Global Fetal Bovine Serum Market
The industry witnessed a trend towards the creation and adoption of animal component-free culture systems. Researchers and manufacturers aimed to decrease reliance on FBS by transitioning to defined media formulations devoid of animal-derived components. This trend aimed to tackle ethical concerns, improve experimental reproducibility, and streamline regulatory compliance.